Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,135,000
-$796,396 QoQ
Shares Held
3,424
-9.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#505
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2021CallValue
$111,708
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Family Manage LLC holds $2,135,000 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,424 | $2,135,000 |
All Filings in REGN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,135,000 | 3,424 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,931,396 | 3,794 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $721,698 | 935 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $554,960 | 987 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,134,650 | 4,066 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,666,302 | 4,204 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,937,648 | 4,124 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,204,960 | 4,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,989,349 | 6,650 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,040,587 | 6,276 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,005,374 | 5,699 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,054,620 | 6,142 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,458,540 | 6,205 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,169,125 | 6,291 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,308,016 | 5,971 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,158,019 | 6,036 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,607,075 | 6,102 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,449,633 | 6,371 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,031,623 | 6,384 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,791,452 | 6,265 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,465,182 | 6,204 | Shares | Sole | 2021-08-13 | |
| 2021-06-30 | $111,708 | 200 | Call | Sole | 2021-08-13 | |
| 2021-03-31 | $3,352,670 | 7,086 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,392,881 | 7,023 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,925,970 | 5,227 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,168,476 | 6,684 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,201,247 | 8,604 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||